CVS Settles Overbilling Medicaid for Insulin

CVS is paying over $365,000 to New Jersey as part of a massive $32.5 million settlement covering 33 states and the federal government, stemming from a decade-long scheme accused of overbilling Medicaid for insulin. Allegedly, CVS dispensed more insulin than prescriptions called for, refilling early and billing for unused supplies — a practice that reportedly led to patients hoarding unused insulin. While CVS claims it wasn’t intentional fraud, citing complex billing and FDA label changes, New Jersey’s Attorney General says CVS knowingly misled about how long insulin would last, enabling the overbilling. With nearly 350 pharmacies in the state, CVS is now settling as part of the broader resolution. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/2b20c6a79c2380de